Teves, Alrenze .

HRN: 13-26-88  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2022
CO-AMOXICLAV 625MG (TAB)
05/22/2022
05/29/2022
PO
625
BID
Lacerated Wound
Waiting Final Action 
05/22/2022
CEFTRIAXONE 1G (VIAL)
05/22/2022
05/22/2022
IV
2g
OD
Traumatic Brain Injury
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: